BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15472802)

  • 1. Prolonged survival of an HIV-infected patient with multidrug-resistant Mycobacterium bovis infection treated with surgical resection.
    Ramos A; Noblejas A; Martin T; Varela A; Daza R; Samper S
    Clin Infect Dis; 2004 Sep; 39(6):e53-5. PubMed ID: 15472802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of multidrug-resistant tuberculosis in San Francisco: an outpatient-based approach.
    Burgos M; Gonzalez LC; Paz EA; Gournis E; Kawamura LM; Schecter G; Hopewell PC; Daley CL
    Clin Infect Dis; 2005 Apr; 40(7):968-75. PubMed ID: 15824988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The stratified tuberculoma caused by Mycobacterium kansasii with cavitation (author's transl)].
    Fingerland A; Forman J; Kovár J; Kroutil J; Kubín M
    Z Erkr Atmungsorgane; 1977 Aug; 149(3):380-7. PubMed ID: 613551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary tuberculosis due to multidrug-resistant Mycobacterium bovis in a healthy host.
    Robles Ruíz P; Esteban J; Guerrero ML
    Clin Infect Dis; 2002 Jul; 35(2):212-3. PubMed ID: 12087533
    [No Abstract]   [Full Text] [Related]  

  • 7. [Exogenous re-infection in tuberculosis].
    Tsuchiya T
    Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleuropulmonary infections caused by Mycobacterium bovis: a re-emerging disease.
    Esteban J; Robles P; Soledad Jiménez M; Fernández Guerrero ML
    Clin Microbiol Infect; 2005 Oct; 11(10):840-3. PubMed ID: 16153260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional and molecular epidemiology of macrolide resistance among new Mycobacterium avium complex isolates recovered from HIV-infected patients.
    Gardner EM; Burman WJ; DeGroote MA; Hildred G; Pace NR
    Clin Infect Dis; 2005 Oct; 41(7):1041-4. PubMed ID: 16142672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolution of drug resistance in Mycobacterium tuberculosis: from a mono-rifampin-resistant cluster into increasingly multidrug-resistant variants in an HIV-seropositive population.
    Bifani P; Mathema B; Kurepina N; Shashkina E; Bertout J; Blanchis AS; Moghazeh S; Driscoll J; Gicquel B; Frothingham R; Kreiswirth BN
    J Infect Dis; 2008 Jul; 198(1):90-4. PubMed ID: 18498237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete resection is mandatory for tubercular cold abscess of the chest wall.
    Kim YT; Han KN; Kang CH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Jan; 85(1):273-7. PubMed ID: 18154822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid for the treatment of multidrug-resistant tuberculosis.
    Fortún J; Martín-Dávila P; Navas E; Pérez-Elías MJ; Cobo J; Tato M; De la Pedrosa EG; Gómez-Mampaso E; Moreno S
    J Antimicrob Chemother; 2005 Jul; 56(1):180-5. PubMed ID: 15911549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
    Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of pulmonary multi-drug resistant tuberculosis with left destroyed lung, treated with pneumonectomy].
    Koyama K; Kawakami K; Harada Y; Yamaryo T; Kimura Y
    Kekkaku; 2007 Jul; 82(7):577-81. PubMed ID: 17695788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistant Mycobacterium bovis disseminated infection.
    Costa FF; Castro G; Andrade J; Jesus Ade R; de Almeida RP; Nascimento-Carvalho CM
    Pediatr Infect Dis J; 2006 Feb; 25(2):190. PubMed ID: 16462308
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam.
    Quy HT; Cobelens FG; Lan NT; Buu TN; Lambregts CS; Borgdorff MW
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):45-51. PubMed ID: 16466036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lingual ulcer as the only sign of recurrent mycobacterial infection in an HIV/AIDS-infected patient.
    Ramírez-Amador V; Anaya-Saavedra G; González-Ramírez I; Mosqueda-Gómez JL; Esquivel-Pedraza L; Reyes-Gutiérrez E; Sierra-Madero J
    Med Oral Patol Oral Cir Bucal; 2005; 10(2):109-14. PubMed ID: 15735542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
    Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
    Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.